- Aucken H M, Ganner M, Murchan S, Cookson B D, Johnson A P. A new UK strain of epidemic methicillin resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics. J Antimicrob Chemother 2002; 50: 171–5
- Barberan J. Management of infections of osteoarticular prosthesis. Clin Microbiol Infect (Suppl 3) 2006; 12: 93–101
- Betsch B Y, Egli S, Siebenrock K A, Täuber M G, Mühle-mann K. Treatment of joint prosthesis infection in accordance with current recommendations improves outcome. Clin Infect Dis 2008; 46(8)1221–1226
- Burger R R, Basch T, Hopson C N. Implant salvage in infected total knee arthroplasty. Clin Orthop 1991, 273: 105–12
- Choong P F, Dowsey M M, Carr D, Daffy J, Stanley P. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampinbased regimen. ActaOrthop 2007; 78(6)755–65
- Giulieri S G, Graber P, Ochsner P E, Zimmerli W. Management of infection associated with total hip arthroplasty according to a treatment algorithm. Infection 2004; 32(4)222–8
- Gottlieb T, Mitchell D. The independent evolution of resistance to ciprofloxacin, rifampicin and fusidic acid in methicillin resistant Staphylococcus aureus in Australian teaching hospitals (1990-1995). Australian Group for Antimicrobial Resistance (AGAR) J Antimicrob Chemother 1998; 42: 67–73
- Laffer R R, Graber P, Ochsner E P, Zimmerli W. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin Microbiol Infect 2006; 12(5)433–9
- Marculescu C E, Berbari E F, Hanssen A D, Steckelberg J M, Harmsen S W, Mandrekar J N, Osmon D R. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 2006; 42(4)471–8
- Medicines for tuberculosis. WHO Drug Information. 2006; 20(4), Available at http://www.who.int/druginformation/vol20num4_2006/DI20-4.pdf. Accessed on 8th Feb 2008.
- Meehan A M, Osmon D R, Duffy M C, Hanssen A D, Keating M R. Outcome of penicillin susceptible streptococcal prosthetic joint infection treated with debridement and retentionof the prosthesis. Clin Infect Dis 2003; 36(7)845–9
- Norazah A, Lim V K E, Koh Y T, Rohani M Y, Zuridah H, Spencer K, Ng P P, Kamel A G M. Molecular fingerprinting of fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals. J Med Microbiol 2002; 51: 1113–6
- Sekiguchi J, Fujino T, Araake M, Toyota E, Kudo K, Saruta K, Yoshikura H, Kuratsuji T, Kirikae T. Emergence of rifampicin resistance in methicillin-resistant Staphylococcus aureus in tuberculosis wards. J Infect Chemother 2006; 12: 47–50
- Srinivasan S, Sheela D, Shashikala, Mathew R, Bazroy J, Kanungo R. Risk factors and associated problems in the management of infections with methicillin resistant Staphylococcus aureus. Indian J Med Micro 2006; 24: 182–5
- Tattevin P, Cremieux A C, Pottier P, Huten D, Carbon C. Prosthetic joint infection:. when can prosthesis salvage be considered? Clin Infect Dis 1999; 29(2)292–5
- Widmer A F, Gaechter A, Ochsner P E, Zimmerli W. Antimicrobial treatment of orthopedic implant-related infections with rifampin combinations. Clin Infect Dis 1992; 14(6)1251–3
- Yourassowksy E, Van der Linden M P, Lismont M J. Combination of minocycline and rifampicin against methicillin and gentamicin-resistant Staphylococcus aureus. J Clin Path 1981; 34: 559–61
- Zimmerli W, Widmer A F, Blatter M, Frei R, Ochsner P E. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. JAMA 1998; 279(19)1537–41
- Zimmerli W, Trampuz A, Ochsner P E. Prosthetic-joint infections. N Engl J Med 2004; 351(16)1645–54
Acta Orthopaedica
Volume 79, 2008 - Issue 3